Evidence map›Paper›PMID 37368148›Full record

ReviewPurinergic signalling2024

Physical exercise as a modulator of the purinergic system in the control of sarcopenia in individuals with chronic kidney disease on hemodialysis.

Débora Tavares de Resende E Silva, Matheus Ribeiro Bizuti, Natan Rodrigues de Oliveira, Lucas Zannini Medeiros Lima, Victória Galletti Dos Santos Arraes, Ana Carolina Gonçalves Zietz, Carolina Zin, Guilherme Vinício de Sousa Silva, Josiano Guilherme Puhle, Fabiana Brum Haag

Open access · greenAbstract readReview
In one paragraph

Review in Purinergic signalling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Exercise as a modulator of purinergic signaling and inflammation in cancer-associated sarcopenia: a narrative review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Débora Tavares de Resende E SilvaDepartment of Graduate Studies in Biomedical Sciences, Federal University of Fronteira Sul (UFFS), Rodovia SC 484-Km 02, Fronteira Sul, Chapecó, SC, CEP 89815-899, Brazil. debora.silva@uffs.edu.br.ORCID 0000-0002-3813-7139
Matheus Ribeiro BizutiDepartment of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil.ORCID 0000-0001-6679-0875
Natan Rodrigues de OliveiraDepartment of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil.ORCID 0000-0002-2758-9092
Lucas Zannini Medeiros LimaDepartment of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil.ORCID 0000-0002-5087-1870
Victória Galletti Dos Santos ArraesDepartment of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil.ORCID 0000-0002-5404-0038
Ana Carolina Gonçalves ZietzDepartment of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil.ORCID 0000-0002-2031-6673
Carolina ZinDepartment of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil.ORCID 0000-0003-2906-5281
Guilherme Vinício de Sousa SilvaDepartment of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil.ORCID 0000-0002-3170-6503
Josiano Guilherme PuhleDepartment of Health Sciences, Western Santa Catarina University, Videira, Santa Catarina, Brazil.ORCID 0000-0003-1607-6571
Fabiana Brum HaagNursing College, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil.ORCID 0000-0001-9345-229X
Universidade Federal da Fronteira Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The word sarcopenia derives from the Greek terms "sarx" for meat and "penia" for loss, thus being used to define reductions in muscle mass, muscle strength, and lower physical performance that compromise, mainly, the elderly population. Its high negative impact on patients' quality of life encourages the production and publication of new studies that seek to find methods to prevent and reverse cases of loss of muscle mass and strength. Furthermore, the high prevalence of sarcopenia in patients with chronic kidney disease (CKD) is closely related to its pathophysiology, which consists of a state of increased protein catabolism and decreased muscle tissue synthesis. Also considering the inflammatory nature of CKD and sarcopenia, the purinergic system has been an important target of studies, which seek to relate it to the two previous conditions. This system achieves anti-inflammatory action by inhibiting, through adenosine, pro-inflammatory factors such as interleukin-12 (IL-12), tumor necrosis factor alpha (TNF-α), and nitric oxide (NO), as well as by releasing anti-inflammatory substances such as interleukin-10 (IL-10). Simultaneously, the purinergic system presents pro-inflammatory activity, signaled by adenosine triphosphate (ATP), which occurs through the activation of T cells and the release of pro-inflammatory factors such as those mentioned above. Therefore, the ability of this system to act on inflammatory processes can promote positive and negative changes in the clinical aspect of patients with CKD and/or sarcopenia. Furthermore, it appears that there is a correlation between the practice of repeated physical exercise with the clinical improvement and in the quality of life of these patients, presenting a decrease in the levels of C-reactive protein (CRP), NTPDase, and the pro-inflammatory cytokine IL-6, such as increases in IL-10 resulting from modulation of the purinergic system. In this way, the present article seeks to evaluate the effect of physical exercise as a modulator of the purinergic system in the control of sarcopenia in patients with CKD on hemodialysis, in order to trace a relationship that can bring benefits both for biological markers and for quality of life of these patients.

Indexed as

ExerciseRenal DialysisRenal Insufficiency, ChronicSarcopeniaHumansChronic renal insufficiencyInflammationPurinergicSarcopenia

Identifiers

PMID37368148
PMCPMC11189381
OpenAlexW4382181532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.